Emergent BioSolutions Inc. — Director's Dealing 2025

Mar 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-03-06

Reporting Person: PAPA JOSEPH C (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-06	Common Stock	A	282500	—	Acquired	282500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-06	Employee Stock Options (Right to Buy)	$5.80	A	282500	Acquired	2032-03-05	Common Stock (282500)	Direct

Footnotes

F1: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each performance stock unit represents a right to receive one share of common stock. The performance stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company and upon achievement with respect to Adjusted EBITDA for the 2025 fiscal year, as certified by the Compensation Committee following the performance period.

F2: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.